Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB. (Q39831195)

15 September 2017

Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB. (English)

1 reference

15 September 2017

0 references

0 references

0 references

1 reference

7

1 reference

15 September 2017

Leyre Mestre

3

0 references

Fabian Docagne

object named as

Fabian Docagne

6

0 references

author name string

Fernando Correa

1

1 reference

15 September 2017

Miriam Hernangómez

2

1 reference

15 September 2017

Frida Loría

4

1 reference

15 September 2017

Alessandra Spagnolo

5

1 reference

15 September 2017

Carmen Guaza

8

1 reference

15 September 2017

language of work or name

1 reference

1 January 2010

1 reference

15 September 2017

1 reference

15 September 2017

58

1 reference

15 September 2017

2

1 reference

15 September 2017

135-147

1 reference

CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies

15 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Macrophage deactivation by interleukin 10

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Cannabinoid receptors in microglia of the central nervous system: immune functional relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Peptidoglycan induces nuclear factor-kappaB activation and cyclooxygenase-2 expression via Ras, Raf-1, and ERK in RAW 264.7 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Thyroid hormone-mediated activation of the ERK/dual specificity phosphatase 1 pathway augments the apoptosis of GH4C1 cells by down-regulating nuclear factor-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

A role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

MAP kinases in the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Role of antigen-presenting cells in the polarized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Inhibition of IL-6, TNF-alpha, and cyclooxygenase-2 protein expression by prostaglandin E2-induced IL-10 in bone marrow-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Chronic neurologic disease in Theiler's virus infection of SJL/J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-kappaB-induced CCAAT/enhancer-binding protein delta in mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Presence and regulation of the endocannabinoid system in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Strategies for use of IL-10 or its antagonists in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Cannabinoid signaling in glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

NF-kappaB: a key role in inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Cytokine cross-talk between phagocytic cells and lymphocytes: relevance for differentiation/activation of phagocytic cells and regulation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Suppression of interleukin-12 production through endogenously secreted interleukin-10 in activated dendritic cells: involvement of activation of extracellular signal-regulated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Role of mitogen-activated protein kinases and NF-kappaB in the regulation of proinflammatory and anti-inflammatory cytokines by Porphyromonas gingivalis hemagglutinin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

Interleukin-10 inhibits interleukin-12 p40 gene transcription by targeting a late event in the activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

ERK1-/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

Therapeutic action of cannabinoids in a murine model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

Differential regulation of IL-12 and IL-10 gene expression in macrophages by the basic leucine zipper transcription factor c-Maf fibrosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+WIN55,212

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

Therapeutic potential of CB2 targeting in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

Therapeutic potential of cannabinoid-based drugs.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

Th2 cytokine production from mast cells is directly induced by lipopolysaccharide and distinctly regulated by c-Jun N-terminal kinase and p38 pathways

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

Understanding the IL-23-IL-17 immune pathway

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

Interleukin-10 induction by IL-12: a possible modulatory mechanism?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

TLR agonists promote ERK-mediated preferential IL-10 production of regulatory dendritic cells (diffDCs), leading to NK-cell activation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

Nonpsychotropic cannabinoid receptors regulate microglial cell migration.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.20907

7 January 2021

Identifiers

DOI

10.1002/GLIA.20907

1 reference

15 September 2017

1 reference